Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 310 for “"viral vector"”.

  1. Novel viral vector vaccines for tropical infections

    … vaccine exists for either tropical infection. Viral vectors are showing great promise as a novel vaccine platform technology, having been shown to induce both cellular and humoral immune responses. Malaria vaccine efficacy can be assessed using controlled human malaria infection (CHMI) studies, …

    oxford Repository record for Novel viral vector vaccines for tropical infections (opens in a new tab)

  2. Biodegradable pulsatile release technologies for viral vector based vaccinations

    … towards non-compliance with subsequent doses. Viral vectored vaccines represent arguably the next generation of vaccines but they too often require a heterologous prime-boost approach such as the use of Adenoviral-MVA vectors. This thesis describes work utilising biodegradable microparticulate …

    oxford Repository record for Biodegradable pulsatile release technologies for viral vector based vaccinations (opens in a new tab)

  3. Evaluation of Murine Cytomegalovirus as a Potential Viral Vector

    … potential utility of mCMV as an antigen delivery vector. In the present study, we further examined the nature of abortive infection that mCMV undergoes in human DCs and the mechanisms of DCs activation by mCMV. Human DCs were prepared from peripheral blood and characterized by immunophenotyping …

    sdstate Repository record for Evaluation of Murine Cytomegalovirus as a Potential Viral Vector (opens in a new tab)

  4. Investigating recombinant AAV (rAAV) gene therapy viral vector production

    … by correcting an underlying genetic abnormality. Viral vector systems account for more than 70% of gene therapy delivery vehicles, with the Adeno-Associated Virus (AAV) system the most widely utilised. AAV is a non-enveloped dependovirus with a number of serotypes that can be used to target …

    kent Download PDF for Investigating recombinant AAV (rAAV) gene therapy viral vector production (opens in a new tab)

  5. Viral vector construction, production and vector-mediated gene transduction

    Until now, viral vectors are considered necessary for gene therapy, and current approaches are prohibited from wide applications mainly due to low efficiency and genotoxicity. The use of optimized vector production systems, the right choice of target cells, and improved transduction protocols may …

    hawaii Repository record for Viral vector construction, production and vector-mediated gene transduction (opens in a new tab)

  6. Development of a CENH3-based and non-viral vector system

    New vectors for successful transgene delivery in patients are more than needed. Current gene therapeutic vectors are mostly based on virus genomes. A main reason is the very efficient administration of the vector into the target cells. The viral background of these systems also has severe side …

    lmu-germany Repository record for Development of a CENH3-based and non-viral vector system (opens in a new tab)

  7. Developing combination therapy to improve viral vector cancer vaccine efficacy

    The development of effective cancer immunotherapies presents several major challenges that must be considered. Notably, it requires the generation of specific immune responses against cancer cells whilst counteracting the highly immunosuppressive mechanisms of the tumour microenvironment. …

    oxford Repository record for Developing combination therapy to improve viral vector cancer vaccine efficacy (opens in a new tab)

  8. Enhancing the efficacy of viral vector blood-stage malaria vaccines

    … (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This thesis describes a number of …

    oxford Repository record for Enhancing the efficacy of viral vector blood-stage malaria vaccines (opens in a new tab)

  9. ENHANCING PERIPHERAL OPIOID ANALGESIA: DEVELOPMENT OF VIRAL VECTOR AND SMALL PEPTIDE THERAPIES

    … can be enhanced using a herpes simplex virus vector gene therapy approach and peripheral opioid tolerance can be prevented by blocking opioid receptor heterodimerization using a small peptide inhibitor in neuropathic pain conditions in rodents. L5 spinal nerve transection was used to model …

    south-carolina Repository record for ENHANCING PERIPHERAL OPIOID ANALGESIA: DEVELOPMENT OF VIRAL VECTOR AND SMALL PEPTIDE THERAPIES (opens in a new tab)

  10. Viral vector-mediated CRISPR-Cas9 gene editing for fundamental and applied plant research

    … manuscript, we demonstrated the use of plant viral vectors to deliver editing reagents into the model plant Nicotiana benthamiana, aiming to regulate stomatal development for functional characterization and enhanced drought tolerance. In the third manuscript, we extended this technique to the …

    umn Repository record for Viral vector-mediated CRISPR-Cas9 gene editing for fundamental and applied plant research (opens in a new tab)

  11. Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches

    … Adenovirus and Modified Vaccinia Ankara-vectored vaccines encoding pre-erythrocytic malaria antigens in mice. Cellular immunogenicity directed against a well-documented epitope of the <em>Plasmodium berghei</em> circumsporozoite protein is evaluated, as is protection against lethal <em>P. …

    oxford Repository record for Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches (opens in a new tab)

  12. DEVELOPMENT OF ANTI-ENTEROVIRUS VACCINES BASED ON REPLICON RNA AND VIRAL VECTOR TECHNOLOGIES

    … pathologies. However, key aspects of viral replication are still not well-understood, and the anti-enterovirus strategies are limited to currently licensed vaccines against only two enteroviruses. This dissertation addresses some of these challenges through three interconnected …

    maryland Repository record for DEVELOPMENT OF ANTI-ENTEROVIRUS VACCINES BASED ON REPLICON RNA AND VIRAL VECTOR TECHNOLOGIES (opens in a new tab)

  13. INVESTIGATING THE CLASSICAL NON-HOMOLOGOUS END JOINING PATHWAY IN THE VIRAL VECTOR AEDES AEGYPTI

    Aedes aegypti is a critical viral vector and is known to transmit yellow fever, dengue and Zika viruses. Current control mechanisms rely heavily on source removal and insecticide use making novel genetic control mechanisms an attractive alternative. The CRISPR/Cas9 system enhances basic and applied …

    tamu Repository record for INVESTIGATING THE CLASSICAL NON-HOMOLOGOUS END JOINING PATHWAY IN THE VIRAL VECTOR AEDES AEGYPTI (opens in a new tab)

  14. Developing SINrep5 as a Viral Vector Platform to Test SARS-CoV-2 Vaccine Candidates

    … and immunization in the arms race against novel viral agents. SARS-CoV-2 vaccines target the mutation-prone Spike Protein, leading to the rise of viral variants, and warranting additional research into the potential of diversifying vaccine target candidates, as well as vaccine options. One …

    calgary Repository record for Developing SINrep5 as a Viral Vector Platform to Test SARS-CoV-2 Vaccine Candidates (opens in a new tab)

  15. Heterologous Prime-Boost strategies using live-attenuated and viral vector vaccines to combat pneumonic plague

    … utilizing either 2-doses of an adenovirus vector (Ad5-YFV) or a heterologous strategy utilizing Ad5-YFV and a live-attenuated (LMA) vaccine were evaluated for protective efficacy against pneumonic plague. A single immunization event giving both Ad5-YFV and LMA at once was also tested as a …

    utmb Repository record for Heterologous Prime-Boost strategies using live-attenuated and viral vector vaccines to combat pneumonic plague (opens in a new tab)

  16. Adeno-Associated Viral Vector-Driven Expression of Coagulation Proteins for Treatment of Hemophilias and Cancer

    Treatment of hemophilia, which involves infusion of the missing clotting factor, is often hindered by the development of neutralizing antibodies to the replaced clotting factor. We utilized liver-directed AAV gene therapy to tolerize outbred hemophiliac dogs with pre-existing anti-factor VIII and …

    penn Repository record for Adeno-Associated Viral Vector-Driven Expression of Coagulation Proteins for Treatment of Hemophilias and Cancer (opens in a new tab)

  17. The impact of cytomegalovirus infection and viral vector vaccination on human and mouse immune systems

    <p>Viral vectors are a next-generation vaccine platform that elicit a robust response from the humoral and cellular arms of the immune system. The importance of this vaccine platform was demonstrated during this PhD with the emergence of SARS-CoV-2 and the development of the chimpanzee …

    oxford Repository record for The impact of cytomegalovirus infection and viral vector vaccination on human and mouse immune systems (opens in a new tab)

Page 1 of 16